 reuters    drugmaker valeant pharmaceuticals international inc s  vrx to  new chief executive  joseph papa  will receive a base salary of    million  the company said in a filing on wednesday  valeant said on monday former perrigo co plc  prgo n  head papa would replace michael pearson as its ceo  papa will also receive a cash payment of   million to make up for the equity based compensation he forfeited in connection with the termination of his employment with perrigo   valeant said in march pearson was leaving the company  just three weeks after returning from a two month medical leave   pearson s base salary for full year  was   million and his total compensation amounted to    million  according to a regulatory filing    usa gov   